Minka Therapeutics was originally created to exploit the 3S/P44L platform and mechanism of actions in the treatment of HIV. Today, its science has broad applications in the field of infectious diseases and oncology.
Company (Alive / Active)
28 rue de l'Amiral Hamelin
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)